PT-141 has real human trial and label data behind its side-effect profile. Across the RECONNECT Phase 3 trials and its long-term extension, the most common reactions were nausea, flushing, and headache, mostly mild to moderate, with nausea affecting a substantial share of users and occasionally leading people to stop.[1][2]
Reviewed for accuracy · Last reviewed July 7, 2026The label also documents a transient increase in blood pressure and a decrease in heart rate after each dose, usually resolving within about 12 hours, which is why it is not recommended in uncontrolled hypertension or known cardiovascular disease and why dosing frequency is capped. With repeated dosing, focal darkening of the skin (including the face and gums) has been reported, more often in people with darker skin or who dose frequently.
Nausea is the effect most likely to be bothersome and is often worst early. Because of the transient blood-pressure effect, dosing more often than the label allows is discouraged, and cardiovascular concerns are a reason to involve a doctor rather than self-manage.
This page is an independent educational reference and is not medical advice. Talk to a doctor before starting any compound.